Skip to main content
Fig. 10 | BMC Musculoskeletal Disorders

Fig. 10

From: Application of vancomycin-impregnated calcium sulfate hemihydrate/nanohydroxyapatite/carboxymethyl chitosan injectable hydrogels combined with BMSC sheets for the treatment of infected bone defects in a rabbit model

Fig. 10

Quantitative analysis of newborn bone tissue was performed in the four groups at 4 weeks, 8 weeks and 12 weeks after the operation (ns, p ≥ 0.05; *, p < 0.05; **, p < 0.01; ***, p < 0.001). At 4 weeks, there was a statistically significant difference in new bone formation among the four groups, while up to 12 weeks, there was no difference among the three Groups B, C, and D

Back to article page